Curriculum

Spotlight on Pneumococcal Disease Prevention: Implementing Current Recommendations

This curriculum offers two engaging Clinical Coffee Break activities with expert faculty discussion to deepen understanding of pneumococcal disease prevention. Clinicians will examine the risks of invasive and non-invasive pneumococcal disease in various adult populations, including those with chronic conditions, and explore the broader public health impact of prevention. Additionally, the curriculum provides a clear summary of ACIP vaccine recommendations, helping providers implement age- and condition-specific guidelines effectively in clinical practice.

doctor administering vaccine

CME Information

1.00 AMA PRA Category 1 Credits™, 1.00 ABIM MOC or 0.90 AANP

Release Date: 12/6/2024

Available for credit until 12/6/2025

Learning Objectives

  • Describe the risk of invasive and non-invasive pneumococcal disease in adults with and without chronic conditions
  • Outline the public health benefit of pneumococcal disease prevention
  • Summarize ACIP recommendations for pneumococcal vaccines based on age and underlying medical conditions
 

Courses

1.00 CME/CE CREDIT

2 Courses

Faculty

Rachel Caskey, MD, MAPP

Associate Professor of Pediatrics and Internal Medicine, Chief of the Division of General Internal Medicine, University of Illinois at Chicago, Chicago, IL

Scott Roberts, MD, MS

Assistant Professor, Infectious Diseases, Yale University School of Medicine, New Haven, CT

Supported By

Merck Sharp & Dohme LLC

Education Partner

Pri-Med Institute